HF Sinclair Corporation Common Stock vs GSK plc — how do they compare? HF Sinclair Corporation Common Stock trades at $120.83 (market cap $21.46B), while GSK plc trades at $46.54 (market cap $91.88B). The key difference: GSK plc is far larger — about 4.3× HF Sinclair Corporation Common Stock's market cap, and GSK plc pays the higher dividend (3.9%). Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and GSK plc for 93 Days on average.
| DINO | GSK | |
|---|---|---|
Market Cap | $21.46B | $91.88B |
Volume | 2,430,580 | 7,730,529 |
Sector | Energy | Health |
52-Week High | $120.72 | $61.18 |
52-Week Low | $45.88 | $43.24 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $22.44B | $111.88B |
Dividend Yield | 1.74% | 3.9% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GSK trades at $46.50, down 1.11% with bearish technical signals, though RSI levels suggest potential oversold conditions. Fundamentally, the company shows strong profitability with 72.73% gross margins and consistent earnings beats, while maintaining a reasonable P/E of 14.89. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite facing an HIV patent cliff.
GSK presents a mixed investment case with strong fundamentals and pipeline growth offset by technical weakness and patent expiration risks. The company's £40B sales target and cost-saving initiatives provide upside potential, while analyst consensus leans cautious with 55% hold ratings. Key risks include execution of pipeline development and competitive pressures in core markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →